{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:48:56Z","timestamp":1794584936074,"version":"4.9.1"},"reference-count":8,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Heart"],"DOI":"10.1136\/heartjnl-2026-328686","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T17:20:20Z","timestamp":1785777620000},"page":"heartjnl-2026-328686","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Aspirin discontinuation after percutaneous coronary intervention for acute coronary syndromes"],"prefix":"10.1136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6943-278X","authenticated-orcid":false,"given":"Felice","family":"Gragnano","sequence":"first","affiliation":[{"name":"Department of Translational Medical Sciences, University of Campania \"Luigi Vanvitelli\", Caserta, Italy"},{"name":"Division of Clinical Cardiology, A.O.R.N. \"Sant'Anna e San Sebastiano\", Caserta, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Calabr\u00f2","sequence":"additional","affiliation":[{"name":"Department of Translational Medical Sciences, University of Campania \"Luigi Vanvitelli\", Caserta, Italy"},{"name":"Division of Clinical Cardiology, A.O.R.N. \"Sant'Anna e San Sebastiano\", Caserta, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"2026080310201356000_heartjnl-2026-328686v1.1","doi-asserted-by":"crossref","first-page":"e653","DOI":"10.4244\/EIJ-E-26-00003","article-title":"Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks. A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology","volume":"22","author":"Gorog","year":"2026","journal-title":"EuroIntervention"},{"key":"2026080310201356000_heartjnl-2026-328686v1.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(24)01616-7"},{"key":"2026080310201356000_heartjnl-2026-328686v1.3","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/eurheartj\/ehaf718","article-title":"Aspirin or P2Y12 inhibitor monotherapy in atherosclerotic cardiovascular disease?","volume":"47","author":"Galli","year":"2026","journal-title":"Eur Heart J"},{"key":"2026080310201356000_heartjnl-2026-328686v1.4","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-082561","article-title":"P2Y12 inhibitor or aspirin after percutaneous coronary intervention: individual patient data meta-analysis of randomised clinical trials","volume":"389","author":"Giacoppo","year":"2025","journal-title":"BMJ"},{"key":"2026080310201356000_heartjnl-2026-328686v1.5","doi-asserted-by":"crossref","unstructured":"Bujak K , Laudani C , Rinaldi R , et al . Optimal timing of aspirin discontinuation after acute coronary syndrome treated with percutaneous coronary intervention: a systematic review and meta-analysis. Heart 2026. doi:10.1136\/heartjnl-2026-328334","DOI":"10.1136\/heartjnl-2026-328334"},{"key":"2026080310201356000_heartjnl-2026-328686v1.6","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1161\/CIRCULATIONAHA.126.079221","article-title":"Clopidogrel Versus Aspirin Monotherapy in Coronary Artery Disease: A Sex-Stratified Individual Patient Data Meta-Analysis of Randomized Trials","volume":"153","author":"Gragnano","year":"2026","journal-title":"Circulation"},{"key":"2026080310201356000_heartjnl-2026-328686v1.7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1161\/CIRCULATIONAHA.121.056878","article-title":"Estimation of DAPT Study Treatment Effects in Contemporary Clinical Practice: Findings From the EXTEND-DAPT Study","volume":"145","author":"Butala","year":"2022","journal-title":"Circulation"},{"key":"2026080310201356000_heartjnl-2026-328686v1.8","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/j.jcin.2024.08.022","article-title":"Antithrombotic Therapy in High Bleeding Risk, Part I: Percutaneous Cardiac Interventions","volume":"17","author":"Galli","year":"2024","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/heartjnl-2026-328686","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T17:20:21Z","timestamp":1785777621000},"score":1,"resource":{"primary":{"URL":"https:\/\/heart.bmj.com\/lookup\/doi\/10.1136\/heartjnl-2026-328686"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":8,"alternative-id":["10.1136\/heartjnl-2026-328686"],"URL":"https:\/\/doi.org\/10.1136\/heartjnl-2026-328686","relation":{},"ISSN":["1355-6037","1468-201X"],"issn-type":[{"value":"1355-6037","type":"print"},{"value":"1468-201X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]}}}